NCT06731725View on ClinicalTrials.gov

Post-marketing Study Focused on Evaluating I+Med's DayDrop for Improving Signs and Symptoms of Mild/Moderate Dry Eye

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 17, 2021

Primary Completion Date

March 31, 2021

Study Completion Date

February 23, 2022

Conditions
Dry EyeDry Eye Syndrome (DES)
Interventions
DEVICE

DayDrop®

The patient will administer 1 to 2 instillations each time it is necessary (at least 2 times a day) and will record it in their data collection notebook.

Trial Locations (1)

01009

Hospital Universitario Araba, Vitoria-Gasteiz

Sponsors
All Listed Sponsors
collaborator

Bioaraba Health Research Institute

NETWORK

lead

i+Med S.Coop.

INDUSTRY